Clinical Trial Update: Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating curcumin and piperine in patients under surveillance for monoclonal gammopathy, smoldering multiple myeloma, or prostate cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy of Undetermined Significance
• Multiple Myeloma
• Prostate Cancer
• Smoldering Multiple Myeloma

Drugs mentioned

• Curcumin (curcumin)
• Piperine (Piperine)

Snippet

Sponsor: University of Rochester | Conditions: Prostate Cancer, Multiple Myeloma | Phase 2 | Status: RECRUITING